Barclays sets $255 target on Reinsurance Group shares

EditorLina Guerrero
Published 04/09/2024, 22:24
Barclays sets $255 target on Reinsurance Group shares
RGA
-

On Wednesday, Barclays began coverage of Reinsurance Group of America (NYSE:RGA), assigning the stock an Overweight rating and setting a price target of $255.00. The firm's analyst cited a positive outlook for the company's revenue growth and earnings potential within the life insurance industry over the forthcoming year.

Reinsurance Group of America is anticipated to exhibit the most consistent revenue growth and earnings among its peers in the life insurance sector. This growth is expected to enhance the visibility of the company's book value per share (BVPS) compounding, which is likely to propel the stock value upward under various market scenarios.

The analyst also highlighted the favorable competitive landscape for Reinsurance Group of America, particularly in the reinsurance of biometric risk. The company is poised to benefit from the current focus of its main multiline reinsurance competitors in Europe on other areas.

This shift could present RGA with increased opportunities, especially in light of the recent challenges faced by SCOR's Life & Health reinsurance business and the consequent need for repricing actions.

Additionally, the presence of private equity-backed reinsurance companies in the market does not seem to pose a direct competition for Reinsurance Group of America. These newer market entrants typically shy away from the biometric risk that constitutes RGA's core facultative risk expertise, thus not encroaching on the company's niche.

In other recent news, Reinsurance Group of America (RGA) has been making significant strides in its business operations. The company reported robust Q2 performance for 2024, with adjusted operating earnings of $5.48 per share, surpassing analyst expectations. Growth was observed across all business lines and geographies, with an increase in adjusted operating return on equity to 15.3%.

RGA has also sealed a substantial coinsurance deal with American National Insurance Company, involving the transfer of approximately $3.5 billion in statutory reserves to RGA's subsidiaries. This move is set to expand RGA's footprint in the life insurance sector and underscores its capability to deliver tailored reinsurance solutions.

In addition, RGA has announced the appointment of Axel André as Executive Vice President and Chief Financial Officer, bringing his experience from American Equity Investment Life (NYSE:AEL) Holding Company and Jackson Financial Inc (NYSE:JXN)., among others. Piper Sandler and RBC Capital Markets have both maintained positive ratings on RGA, reflecting confidence in the company's strategic positioning and growth prospects.

The company's strategic capital deployment was reported at $307 million, and a 4.7% dividend increase to $0.89 per share reflects a confident outlook. Despite a higher-than-expected effective tax rate for the quarter, RGA maintains a strong capital and liquidity position, with excess capital of about $1 billion.

InvestingPro Insights

As Barclays initiates coverage on Reinsurance Group of America with a positive outlook, InvestingPro data and tips provide additional context for investors considering the stock. With a market capitalization of $14.42 billion and a P/E ratio of 16.77, RGA appears to be trading at a valuation that reflects its near-term earnings growth potential. The company's revenue has shown a significant increase over the last twelve months as of Q2 2024, with a growth rate of 27.13%, supporting Barclays' optimistic view of the company's revenue trajectory.

An InvestingPro Tip highlights that Reinsurance Group of America has raised its dividend for 14 consecutive years, which could be a testament to its financial stability and commitment to returning value to shareholders. Moreover, the company's liquid assets exceed its short-term obligations, indicating a strong liquidity position. For investors interested in the company's dividend reliability and financial health, these insights could be particularly relevant.

InvestingPro also notes that there are additional tips available that could provide further depth to an investor's research. For those looking to explore more about Reinsurance Group of America's financials and market performance, additional tips can be found on the InvestingPro platform.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.